STOCK TITAN

Twist Bioscience insider plans sale of 5,875 shares on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Insider sale notice: A Form 144 was filed indicating a proposed sale of 5,875 common shares of Twist Bioscience Corp (TWST) with an aggregate market value of $189,098.63. The shares were acquired on 10/01/2025 via restricted stock vesting and the filing lists an approximate sale date of 10/06/2025 on NASDAQ. The filing reports 60,360,925 shares outstanding, making the proposed block roughly 0.0097% of the outstanding shares. The filer previously sold 2,449 shares on 07/09/2025 for $93,419.31 and 918 shares on 08/21/2025 for $23,835.14. The acquisition was recorded as compensation on 10/01/2025. The filer certifies no undisclosed material adverse information.

Positive

  • Securities acquired via restricted stock vesting, indicating compensation alignment with company performance
  • Proposed sale is immaterial at ~0.0097% of outstanding shares, limiting dilution and market impact

Negative

  • Insider is selling vested shares, which can create modest supply to the market near 10/06/2025

Insights

Small, routine insider sale from vested compensation; minimal dilution.

The notice shows a planned disposal of 5,875 shares acquired by restricted stock vesting and listed for sale at an aggregate of $189,098.63. That block equals about 0.0097% of the reported 60,360,925 shares outstanding, so the transaction is immaterial to capital structure.

Dependencies and risks are limited: the sale originates from compensation vesting and follows two prior small sales in 07/2025 and 08/2025. Market impact is unlikely; monitor reported sale execution on or near 10/06/2025 for confirmation.

Vested equity sold as compensation income, not an external financing event.

The securities were acquired on 10/01/2025 through vesting and the payment nature is listed as compensation, indicating these were earned shares rather than purchased. Such transactions commonly reflect routine pay realization by insiders.

Key items to watch are any subsequent filings that show whether the sale executed at the stated date and whether similar small disposals continue in the near term, which could reflect planned liquidity rather than a change in confidence.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the TWST Form 144 report?

The Form 144 reports a proposed sale of 5,875 common shares valued at $189,098.63, with an approximate sale date of 10/06/2025.

How were the shares acquired for the TWST sale?

The shares were acquired on 10/01/2025 through restricted stock vesting and the payment nature is listed as compensation.

How large is the proposed sale relative to TWST outstanding shares?

The proposed block of 5,875 shares is about 0.0097% of the reported 60,360,925 shares outstanding.

Did the filer sell other TWST shares recently?

Yes. The filing lists prior sales by the same person: 2,449 shares on 07/09/2025 for $93,419.31 and 918 shares on 08/21/2025 for $23,835.14.

On which exchange is TWST listed for the proposed sale?

The proposed sale is listed on NASDAQ.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.77B
60.26M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO